tiprankstipranks
Zentalis Pharmaceuticals (ZNTL)
NASDAQ:ZNTL
US Market
ZNTL
Zentalis Pharmaceuticals
RESEARCH TOOLSreports

Zentalis Pharmaceuticals (ZNTL) Income Statement

379 Followers

Zentalis Pharmaceuticals Income Statement

Last quarter (Q4 2025), Zentalis Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Zentalis Pharmaceuticals's net income was $-35.22M. See Zentalis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 67.42M$ 0.00$ 0.00$ 0.00
Gross Profit
$ -739.00K$ 67.42M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 145.01M$ 258.62M$ 299.51M$ 227.29M$ 216.54M
Depreciation and Amortization
$ 739.00K$ 1.29M$ 1.39M$ 1.43M$ 544.00K
EBITDA
$ -145.51M$ -186.17M$ -247.60M$ -225.86M$ -207.20M
Operating Income
$ -146.25M$ -191.19M$ -299.51M$ -227.29M$ -216.54M
Other Income/Expenses
$ 9.63M$ 25.50M$ 6.60M$ -10.29M$ 50.15M
Pretax Income
$ -136.62M$ -165.69M$ -292.91M$ -237.58M$ -166.39M
Net Income
$ -137.06M$ -165.84M$ -292.19M$ -236.81M$ -158.72M
Per Share Metrics
Basic EPS
$ -1.91$ -2.33$ -4.47$ -4.48$ -3.72
Diluted EPS
$ -1.91$ -2.33$ -4.47$ -4.48$ -3.72
Weighted Average Shares Outstanding
 71.87M 71.08M 65.41M 52.86M 42.69M
Weighted Average Shares Outstanding (Diluted)
 71.87M 71.08M 65.41M 52.86M 42.69M
Currency in USD

Zentalis Pharmaceuticals Earnings and Revenue History